Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 115

    1.

    Cutaneous pigmentation after photosensitivity induced by vandetanib therapy.

    Kong HH, Fine HA, Stern JB, Turner ML.

    Arch Dermatol. 2009 Aug;145(8):923-5.PMID: 19687425 [PubMed - indexed for MEDLINE]Related articles

    2.

    Talampanel with standard radiation and temozolomide in patients with newly diagnosed glioblastoma: a multicenter phase II trial.

    Grossman SA, Ye X, Chamberlain M, Mikkelsen T, Batchelor T, Desideri S, Piantadosi S, Fisher J, Fine HA.

    J Clin Oncol. 2009 Sep 1;27(25):4155-61. Epub 2009 Jul 27.PMID: 19636006 [PubMed - indexed for MEDLINE]Related articles

    3.

    Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma.

    Norden AD, Raizer JJ, Abrey LE, Lamborn KR, Lassman AB, Chang SM, Yung WK, Gilbert MR, Fine HA, Mehta M, Deangelis LM, Cloughesy TF, Robins HI, Aldape K, Dancey J, Prados MD, Lieberman F, Wen PY.

    J Neurooncol. 2009 Jun 28. [Epub ahead of print]PMID: 19562255 [PubMed - as supplied by publisher]Related articles

    5.

    Glioma stem cells: better flat than round.

    Woolard K, Fine HA.

    Cell Stem Cell. 2009 Jun 5;4(6):466-7.PMID: 19497271 [PubMed - indexed for MEDLINE]Related articles

    6.

    SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma.

    Son MJ, Woolard K, Nam DH, Lee J, Fine HA.

    Cell Stem Cell. 2009 May 8;4(5):440-52.PMID: 19427293 [PubMed - indexed for MEDLINE]Related articles

    7.

    Common variation in genes related to innate immunity and risk of adult glioma.

    Rajaraman P, Brenner AV, Butler MA, Wang SS, Pfeiffer RM, Ruder AM, Linet MS, Yeager M, Wang Z, Orr N, Fine HA, Kwon D, Thomas G, Rothman N, Inskip PD, Chanock SJ.

    Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1651-8.PMID: 19423540 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    A phase I trial of enzastaurin in patients with recurrent gliomas.

    Kreisl TN, Kim L, Moore K, Duic P, Kotliarova S, Walling J, Musib L, Thornton D, Albert PS, Fine HA.

    Clin Cancer Res. 2009 May 15;15(10):3617-23. Epub 2009 May 5.PMID: 19417015 [PubMed - indexed for MEDLINE]Related articles

    9.

    Glioma stem cells: not all created equal.

    Fine HA.

    Cancer Cell. 2009 Apr 7;15(4):247-9.PMID: 19345322 [PubMed - indexed for MEDLINE]Related articles

    10.

    Phase II study of imatinib mesylate (Gleevec(R)) for recurrent meningiomas (North American Brain Tumor Consortium Study 01-08).

    Wen PY, Yung WK, Lamborn KR, Norden AD, Cloughesy TF, Abrey LE, Fine HA, Chang SM, Robins HI, Fink K, Deangelis LM, Mehta M, Di Tomaso E, Drappatz J, Kesari S, Ligon KL, Aldape K, Jain RK, Stiles CD, Egorin MJ, Prados MD.

    Neuro Oncol. 2009 Mar 17. [Epub ahead of print]PMID: 19293394 [PubMed - as supplied by publisher]Related articles

    11.

    Unsupervised analysis of transcriptomic profiles reveals six glioma subtypes.

    Li A, Walling J, Ahn S, Kotliarov Y, Su Q, Quezado M, Oberholtzer JC, Park J, Zenklusen JC, Fine HA.

    Cancer Res. 2009 Mar 1;69(5):2091-9. Epub 2009 Feb 24.PMID: 19244127 [PubMed - indexed for MEDLINE]Related articles

    12.

    Occupational exposure to magnetic fields and the risk of brain tumors.

    Coble JB, Dosemeci M, Stewart PA, Blair A, Bowman J, Fine HA, Shapiro WR, Selker RG, Loeffler JS, Black PM, Linet MS, Inskip PD.

    Neuro Oncol. 2009 Jun;11(3):242-9. Epub 2009 Feb 20.PMID: 19234232 [PubMed - indexed for MEDLINE]Related articles

    13.

    Rembrandt: helping personalized medicine become a reality through integrative translational research.

    Madhavan S, Zenklusen JC, Kotliarov Y, Sahni H, Fine HA, Buetow K.

    Mol Cancer Res. 2009 Feb;7(2):157-67. Epub 2009 Feb 10.PMID: 19208739 [PubMed - indexed for MEDLINE]Related articles

    14.

    Correlation analysis between single-nucleotide polymorphism and expression arrays in gliomas identifies potentially relevant target genes.

    Kotliarov Y, Kotliarova S, Charong N, Li A, Walling J, Aquilanti E, Ahn S, Steed ME, Su Q, Center A, Zenklusen JC, Fine HA.

    Cancer Res. 2009 Feb 15;69(4):1596-603. Epub 2009 Feb 3.PMID: 19190341 [PubMed - indexed for MEDLINE]Related articles

    15.

    Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma.

    Kreisl TN, Kim L, Moore K, Duic P, Royce C, Stroud I, Garren N, Mackey M, Butman JA, Camphausen K, Park J, Albert PS, Fine HA.

    J Clin Oncol. 2009 Feb 10;27(5):740-5. Epub 2008 Dec 29.PMID: 19114704 [PubMed - indexed for MEDLINE]Related articles

    16.

    Glycogen synthase kinase-3 inhibition induces glioma cell death through c-MYC, nuclear factor-kappaB, and glucose regulation.

    Kotliarova S, Pastorino S, Kovell LC, Kotliarov Y, Song H, Zhang W, Bailey R, Maric D, Zenklusen JC, Lee J, Fine HA.

    Cancer Res. 2008 Aug 15;68(16):6643-51.PMID: 18701488 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Oxidative response gene polymorphisms and risk of adult brain tumors.

    Rajaraman P, Hutchinson A, Rothman N, Black PM, Fine HA, Loeffler JS, Selker RG, Shapiro WR, Linet MS, Inskip PD.

    Neuro Oncol. 2008 Oct;10(5):709-15. Epub 2008 Aug 5.PMID: 18682580 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Invasion suppressor cystatin E/M (CST6): high-level cell type-specific expression in normal brain and epigenetic silencing in gliomas.

    Qiu J, Ai L, Ramachandran C, Yao B, Gopalakrishnan S, Fields CR, Delmas AL, Dyer LM, Melnick SJ, Yachnis AT, Schwartz PH, Fine HA, Brown KD, Robertson KD.

    Lab Invest. 2008 Sep;88(9):910-25. Epub 2008 Jul 7.PMID: 18607344 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Genetic variation in insulin-like growth factors and brain tumor risk.

    Lönn S, Rothman N, Shapiro WR, Fine HA, Selker RG, Black PM, Loeffler JS, Hutchinson AA, Inskip PD.

    Neuro Oncol. 2008 Aug;10(4):553-9. Epub 2008 Jun 18.PMID: 18562769 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Neurooncology clinical trial design for targeted therapies: lessons learned from the North American Brain Tumor Consortium.

    Chang SM, Lamborn KR, Kuhn JG, Yung WK, Gilbert MR, Wen PY, Fine HA, Mehta MP, DeAngelis LM, Lieberman FS, Cloughesy TF, Robins HI, Abrey LE, Prados MD; North American Brain Tumor Consortium.

    Neuro Oncol. 2008 Aug;10(4):631-42. Epub 2008 Jun 17. Review.PMID: 18559968 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Notch-1 regulates transcription of the epidermal growth factor receptor through p53.

    Purow BW, Sundaresan TK, Burdick MJ, Kefas BA, Comeau LD, Hawkinson MP, Su Q, Kotliarov Y, Lee J, Zhang W, Fine HA.

    Carcinogenesis. 2008 May;29(5):918-25. Epub 2008 Mar 20.PMID: 18359760 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Progression-free survival: an important end point in evaluating therapy for recurrent high-grade gliomas.

    Lamborn KR, Yung WK, Chang SM, Wen PY, Cloughesy TF, DeAngelis LM, Robins HI, Lieberman FS, Fine HA, Fink KL, Junck L, Abrey L, Gilbert MR, Mehta M, Kuhn JG, Aldape KD, Hibberts J, Peterson PM, Prados MD; North American Brain Tumor Consortium.

    Neuro Oncol. 2008 Apr;10(2):162-70. Epub 2008 Mar 4.PMID: 18356283 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    FK506 binding protein mediates glioma cell growth and sensitivity to rapamycin treatment by regulating NF-kappaB signaling pathway.

    Jiang W, Cazacu S, Xiang C, Zenklusen JC, Fine HA, Berens M, Armstrong B, Brodie C, Mikkelsen T.

    Neoplasia. 2008 Mar;10(3):235-43.PMID: 18320068 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Genomic changes and gene expression profiles reveal that established glioma cell lines are poorly representative of primary human gliomas.

    Li A, Walling J, Kotliarov Y, Center A, Steed ME, Ahn SJ, Rosenblum M, Mikkelsen T, Zenklusen JC, Fine HA.

    Mol Cancer Res. 2008 Jan;6(1):21-30. Epub 2008 Jan 9.PMID: 18184972 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells.

    Lee J, Son MJ, Woolard K, Donin NM, Li A, Cheng CH, Kotliarova S, Kotliarov Y, Walling J, Ahn S, Kim M, Totonchy M, Cusack T, Ene C, Ma H, Su Q, Zenklusen JC, Zhang W, Maric D, Fine HA.

    Cancer Cell. 2008 Jan;13(1):69-80.PMID: 18167341 [PubMed - indexed for MEDLINE]Related articles

    26.

    A phase I trial of lenalidomide in patients with recurrent primary central nervous system tumors.

    Fine HA, Kim L, Albert PS, Duic JP, Ma H, Zhang W, Tohnya T, Figg WD, Royce C.

    Clin Cancer Res. 2007 Dec 1;13(23):7101-6.PMID: 18056189 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    Promising new therapies for malignant gliomas.

    Fine HA.

    Cancer J. 2007 Nov-Dec;13(6):349-54. Review.PMID: 18032970 [PubMed - indexed for MEDLINE]Related articles

    28.

    Single-nucleotide polymorphisms in selected cytokine genes and risk of adult glioma.

    Brenner AV, Butler MA, Wang SS, Ruder AM, Rothman N, Schulte PA, Chanock SJ, Fine HA, Linet MS, Inskip PD.

    Carcinogenesis. 2007 Dec;28(12):2543-7. Epub 2007 Oct 4.PMID: 17916900 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    Polymorphisms in apoptosis and cell cycle control genes and risk of brain tumors in adults.

    Rajaraman P, Wang SS, Rothman N, Brown MM, Black PM, Fine HA, Loeffler JS, Selker RG, Shapiro WR, Chanock SJ, Inskip PD.

    Cancer Epidemiol Biomarkers Prev. 2007 Aug;16(8):1655-61.PMID: 17684142 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    The 1p-encoded protein stathmin and resistance of malignant gliomas to nitrosoureas.

    Ngo TT, Peng T, Liang XJ, Akeju O, Pastorino S, Zhang W, Kotliarov Y, Zenklusen JC, Fine HA, Maric D, Wen PY, De Girolami U, Black PM, Wu WW, Shen RF, Jeffries NO, Kang DW, Park JK.

    J Natl Cancer Inst. 2007 Apr 18;99(8):639-52.PMID: 17440165 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Lead, genetic susceptibility, and risk of adult brain tumors.

    Rajaraman P, Stewart PA, Samet JM, Schwartz BS, Linet MS, Zahm SH, Rothman N, Yeager M, Fine HA, Black PM, Loeffler J, Shapiro WR, Selker RG, Inskip PD.

    Cancer Epidemiol Biomarkers Prev. 2006 Dec;15(12):2514-20.PMID: 17164378 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    Personal hair dye use and risks of glioma, meningioma, and acoustic neuroma among adults.

    Bluhm EC, Zahm SH, Fine HA, Black PM, Loeffler JS, Shapiro WR, Selker RG, Inskip PD.

    Am J Epidemiol. 2007 Jan 1;165(1):63-71. Epub 2006 Nov 1.PMID: 17079691 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    High-resolution global genomic survey of 178 gliomas reveals novel regions of copy number alteration and allelic imbalances.

    Kotliarov Y, Steed ME, Christopher N, Walling J, Su Q, Center A, Heiss J, Rosenblum M, Mikkelsen T, Zenklusen JC, Fine HA.

    Cancer Res. 2006 Oct 1;66(19):9428-36. Erratum in: Cancer Res. 2007 Mar 1;67(5):2389. PMID: 17018597 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08.

    Wen PY, Yung WK, Lamborn KR, Dahia PL, Wang Y, Peng B, Abrey LE, Raizer J, Cloughesy TF, Fink K, Gilbert M, Chang S, Junck L, Schiff D, Lieberman F, Fine HA, Mehta M, Robins HI, DeAngelis LM, Groves MD, Puduvalli VK, Levin V, Conrad C, Maher EA, Aldape K, Hayes M, Letvak L, Egorin MJ, Capdeville R, Kaplan R, Murgo AJ, Stiles C, Prados MD.

    Clin Cancer Res. 2006 Aug 15;12(16):4899-907.PMID: 16914578 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines.

    Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, Donin NM, Pastorino S, Purow BW, Christopher N, Zhang W, Park JK, Fine HA.

    Cancer Cell. 2006 May;9(5):391-403.PMID: 16697959 [PubMed - indexed for MEDLINE]Related articles

    36.

    Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain.

    Sun L, Hui AM, Su Q, Vortmeyer A, Kotliarov Y, Pastorino S, Passaniti A, Menon J, Walling J, Bailey R, Rosenblum M, Mikkelsen T, Fine HA.

    Cancer Cell. 2006 Apr;9(4):287-300.PMID: 16616334 [PubMed - indexed for MEDLINE]Related articles

    37.

    Variation in genes relevant to aromatic hydrocarbon metabolism and the risk of adult brain tumors.

    De Roos AJ, Rothman N, Brown M, Bell DA, Pittman GS, Shapiro WR, Selker RG, Fine HA, Black PM, Inskip PD.

    Neuro Oncol. 2006 Apr;8(2):145-55. Epub 2006 Jan 27.PMID: 16598069 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    A phase 2 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study.

    Prados MD, Lamborn K, Yung WK, Jaeckle K, Robins HI, Mehta M, Fine HA, Wen PY, Cloughesy T, Chang S, Nicholas MK, Schiff D, Greenberg H, Junck L, Fink K, Hess K, Kuhn J; North American Brain Tumor Consortium.

    Neuro Oncol. 2006 Apr;8(2):189-93. Epub 2006 Mar 13.PMID: 16533878 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    Evaluation of (76)Br-FBAU as a PET reporter probe for HSV1-tk gene expression imaging using mouse models of human glioma.

    Cho SY, Ravasi L, Szajek LP, Seidel J, Green MV, Fine HA, Eckelman WC.

    J Nucl Med. 2005 Nov;46(11):1923-30.PMID: 16269608 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    Monocytes form a vascular barrier and participate in vessel repair after brain injury.

    Glod J, Kobiler D, Noel M, Koneru R, Lehrer S, Medina D, Maric D, Fine HA.

    Blood. 2006 Feb 1;107(3):940-6. Epub 2005 Oct 4.PMID: 16204319 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    Central nervous system cancers: Clinical Practice Guidelines in Oncology.

    Brem SS, Bierman PJ, Black P, Blumenthal DT, Brem H, Chamberlain MC, Chiocca EA, DeAngelis LM, Fenstermaker RA, Fine HA, Friedman A, Glass J, Grossman SA, Heimberger AB, Junck L, Levin V, Loeffler JJ, Maor MH, Narayana A, Newton HB, Olivi A, Portnow J, Prados M, Raizer JJ, Rosenfeld SS, Shrieve DC, Sills AK Jr, Spence AM, Vrionis FD; National Comprehensive Cancer Network.

    J Natl Compr Canc Netw. 2005 Sep;3(5):644-90. No abstract available. PMID: 16194456 [PubMed - indexed for MEDLINE]Related articles

    42.

    Delta-aminolevulinic acid dehydratase polymorphism and risk of brain tumors in adults.

    Rajaraman P, Schwartz BS, Rothman N, Yeager M, Fine HA, Shapiro WR, Selker RG, Black PM, Inskip PD.

    Environ Health Perspect. 2005 Sep;113(9):1209-11.PMID: 16140629 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    Radiotherapy plus adjuvant temozolomide for the treatment of glioblastoma--a paradigm shift.

    Fine HA.

    Nat Clin Pract Oncol. 2005 Jul;2(7):334-5. No abstract available. PMID: 16075787 [PubMed]Related articles

    44.

    Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation.

    Purow BW, Haque RM, Noel MW, Su Q, Burdick MJ, Lee J, Sundaresan T, Pastorino S, Park JK, Mikolaenko I, Maric D, Eberhart CG, Fine HA.

    Cancer Res. 2005 Mar 15;65(6):2353-63.PMID: 15781650 [PubMed - indexed for MEDLINE]Related articlesFree article

    45.

    Self-reported electrical appliance use and risk of adult brain tumors.

    Kleinerman RA, Linet MS, Hatch EE, Tarone RE, Black PM, Selker RG, Shapiro WR, Fine HA, Inskip PD.

    Am J Epidemiol. 2005 Jan 15;161(2):136-46.PMID: 15632263 [PubMed - indexed for MEDLINE]Related articlesFree article

    46.

    Reproductive and hormonal factors and risk of brain tumors in adult females.

    Hatch EE, Linet MS, Zhang J, Fine HA, Shapiro WR, Selker RG, Black PM, Inskip PD.

    Int J Cancer. 2005 May 1;114(5):797-805.PMID: 15609304 [PubMed - indexed for MEDLINE]Related articles

    47.

    Agents with selective estrogen receptor (ER) modulator activity induce apoptosis in vitro and in vivo in ER-negative glioma cells.

    Hui AM, Zhang W, Chen W, Xi D, Purow B, Friedman GC, Fine HA.

    Cancer Res. 2004 Dec 15;64(24):9115-23.PMID: 15604281 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    Progress report on the potential of angiogenesis inhibitors for neuro-oncology.

    Purow B, Fine HA.

    Cancer Invest. 2004;22(4):577-87. Review.PMID: 15565816 [PubMed - indexed for MEDLINE]Related articles

    49.

    Determination of CC-5013, an analogue of thalidomide, in human plasma by liquid chromatography-mass spectrometry.

    Tohnya TM, Hwang K, Lepper ER, Fine HA, Dahut WL, Venitz J, Sparreboom A, Figg WD.

    J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Nov 25;811(2):135-41.PMID: 15522712 [PubMed - indexed for MEDLINE]Related articles

    50.

    Meningioma and schwannoma risk in adults in relation to family history of cancer.

    Hill DA, Linet MS, Black PM, Fine HA, Selker RG, Shapiro WR, Inskip PD.

    Neuro Oncol. 2004 Oct;6(4):274-80.PMID: 15494094 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...